Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

IGM Biosciences, Inc. (IGMS)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income  -64.4-59.3-58.0-58.6-51.9-50.6-44.2-38.7
Depreciation and amortization   [+]2.21.71.51.41.2-3.21.11.4
Stock-based compensation  14.311.010.811.311.5-17.36.25.6
Change in working capital   [+]-5.4-4.15.5155.40.1-4.31.95.0
Other operating activities  0.2-0.3-0.21.80.240.50.6-0.4
Cash from operations  -53.1-51.0-40.4111.3-38.9-34.9-34.4-27.0
   
Capital expenditures  -3.9-3.9-2.7-1.8-3.024.7-2.2-3.2
Purchases of short-term investments, net  -2.473.8-1.0-182.2-16.1259.3-44.923.9
Other cash from investing       -282.2  
Cash from investing  -6.369.8-3.7-184.0-19.11.8-47.120.7
   
Issuance of common stock, net     218.0    
Option exercises  1.00.10.30.50.1 1.50.2
Other cash from financing  71.00.20.61.00.23.52.50.1
Cash from financing  70.00.10.3218.50.13.51.10.0
   
Free cash flow  -57.0-54.9-43.1109.5-41.9-10.2-36.7-30.2
        Per share (diluted)  ($1.26)($1.24)($0.98)$2.49($1.24)($0.30)($1.10)($0.90)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy